Ideal Glucocorticoid Regimen With Abiraterone Acetate: Options and Challenges

JAMA Oncol. 2019 Aug 1;5(8):1167-1169. doi: 10.1001/jamaoncol.2019.1008.

¹ The Holden Comprehensive Cancer Center, Department of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City.
² Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.
³ Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City.

No abstract available